40.10
-0.56
(-1.38%)
As of 8:13:57 AM GMT+1. Market Open.
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 0QF.HA | -- | -- | -- | -- |
| S&P 500 | -- | -- | -- | -- |
Upgrades & Downgrades
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 1/15/2025 |
| Maintains | UBS: Buy to Buy | 1/8/2025 |
| Downgrade | Argus Research: Buy to Hold | 12/18/2024 |
| Maintains | JP Morgan: Underweight to Underweight | 11/26/2024 |
| Reiterates | Piper Sandler: Overweight to Overweight | 11/18/2024 |
| Upgrade | HSBC: Hold to Buy | 11/18/2024 |
Related Tickers
VIRX Viracta Therapeutics, Inc.
0.1715
+7.73%
VYNE VYNE Therapeutics Inc.
2.7600
+3.37%
MSB.AX Mesoblast Limited
2.8700
+3.61%
GRCE Grace Therapeutics, Inc.
3.9000
-2.86%
TIL Instil Bio, Inc.
23.44
-2.88%
CGTX Cognition Therapeutics, Inc.
0.7539
-4.10%
MESO Mesoblast Limited
18.27
+1.39%
MBIO Mustang Bio, Inc.
4.7900
+17.11%
INO Inovio Pharmaceuticals, Inc.
2.1800
-4.80%
ABCL AbCellera Biologics Inc.
3.4800
-1.14%